Despite compound F2S4-p did not show inhibition of AChE and BACE1 activity, but it showed Aβ1–42 aggregation, this molecule could be employed in combination with any of the compounds as an interesting approach employing different mechanisms of action as a more effective way to tackle a complex neurological disease. Here, BACE1 is linked to nervous system disorder.